ROVIDA, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 4.902
EU - Europa 4.161
AS - Asia 855
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
OC - Oceania 1
Totale 9.922
Nazione #
US - Stati Uniti d'America 4.869
PL - Polonia 2.126
IT - Italia 513
SE - Svezia 470
IE - Irlanda 461
CN - Cina 232
HK - Hong Kong 227
RU - Federazione Russa 166
JO - Giordania 132
SG - Singapore 95
FI - Finlandia 87
GB - Regno Unito 85
DE - Germania 84
VN - Vietnam 80
UA - Ucraina 71
IN - India 42
CA - Canada 33
CH - Svizzera 29
BE - Belgio 22
TW - Taiwan 14
FR - Francia 11
TR - Turchia 11
AT - Austria 8
MK - Macedonia 8
KR - Corea 6
ES - Italia 5
NL - Olanda 5
PH - Filippine 5
ID - Indonesia 3
RO - Romania 3
AL - Albania 2
EU - Europa 2
IL - Israele 2
IR - Iran 2
JP - Giappone 2
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
EE - Estonia 1
HU - Ungheria 1
LY - Libia 1
MY - Malesia 1
RS - Serbia 1
Totale 9.922
Città #
Warsaw 2.126
Fairfield 754
Chandler 538
Dublin 456
Ashburn 388
Woodbridge 370
Seattle 328
Cambridge 290
Houston 265
Wilmington 243
Ann Arbor 205
Florence 204
Jacksonville 149
Hong Kong 134
Princeton 119
Lawrence 110
Altamura 104
Beijing 104
Boston 84
Dong Ket 72
Singapore 65
Boardman 64
Buffalo 59
San Diego 55
Shanghai 53
Kent 44
Falls Church 39
Medford 39
Pune 33
Bern 28
Moscow 27
Brussels 22
Norwalk 21
Ottawa 18
Phoenix 17
Milan 15
Los Angeles 14
Redwood City 14
Toronto 14
London 13
Daan 12
Dearborn 12
Andover 11
Rome 11
Vienna 8
Hillsboro 7
Prato 7
Redmond 7
Guangzhou 6
Izmir 6
Munich 6
Turin 6
West Jordan 6
Dallas 5
Laurel 5
Renton 5
Siena 5
Tappahannock 5
Barcelona 4
Cagliari 4
Cisano Bergamasco 4
Costa Mesa 4
Helsinki 4
Notre Dame 4
Castelliri 3
Detroit 3
Foggia 3
Fuzhou 3
Hangzhou 3
Islington 3
Kilburn 3
Lappeenranta 3
Lynchburg 3
Malang 3
Menlo Park 3
Mumbai 3
New York 3
Ohrid 3
Anghiari 2
Augusta 2
Bologna 2
Bremen 2
Düsseldorf 2
Fremont 2
Garden Grove 2
Hounslow 2
Kaohsiung City 2
Karlskrona 2
Karlsruhe 2
Kochi 2
Nuremberg 2
Pavia 2
Poggio a Caiano 2
Prescot 2
Rho 2
Rubano 2
San Juan 2
San Mateo 2
Sesto Fiorentino 2
Silea 2
Totale 7.937
Nome #
The Colony-Stimulating Factor-1 (CSF-1) Receptor Sustains ERK1/2 Activation and Proliferation in Breast Cancer Cell Lines. 269
One more stem cell niche: how the sensitivity of chronic myeloid leukemia cells to imatinib mesylate is modulated within a “hypoxic” environment 255
The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy. 247
Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine. 237
The Leukemic Stem Cell Niche: Adaptation to “Hypoxia” versus Oncogene Addiction 237
Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells. 235
Hypoxia-resistant profile implies vulnerability of cancer stem cells to physiological agents, which suggests new therapeutic targets. 228
The complex metabolic network gearing the G1/S transition in leukemic stem cells: Hints to a rational use of antineoplastic agents. 226
ERK5 is activated by oncogenic BRAF and promotes melanoma growth 223
The expansion of murine bone marrow cells preincubated in hypoxia as an in vitro indicator of their marrow-repopulating ability. 219
Chronic myeloid leukemia and hepatoblastoma: Two cancer models to link metabolism to stem cells 219
Hypoxia selects bortezomib-resistant stem cells of chronic myeloid leukemia. 218
Colony-Stimulating Factor-1 Receptor in the Polarization of Macrophages: A Target for Turning Bad to Good Ones? 212
Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells. 200
Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells 183
The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma. 163
Low-dose methotrexate enhances cycling of highly anaplastic cancer cells. 147
Impact of ERK5 on the Hallmarks of Cancer 147
Different BCR/Abl protein suppression patterns as a converging trait of chronic myeloid leukemia cell adaptation to energy restriction 141
The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells 129
Fibronectin induces macrophage migration through a SFK-FAK/CSF-1R pathway 127
Beyond Kinase Activity: ERK5 Nucleo-Cytoplasmic Shuttling as a Novel Target for Anticancer Therapy 119
1,25-dihydroxyvitamin D3 and erk ½ map kinases in a human chronic myeloid leukemia cell line 114
Glucose availability in hypoxia regulates the selection of chronic myeloid leukemia progenitor subsets with different resistance to imatinib-mesylate 114
AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia 110
In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features 101
HYPOXIA SUPPRESSES BCR/ABL AND SELECTS IMATINIB-INSENSITIVE PROGENITORS WITHIN CLONAL CML POPULATIONS. 100
ACTIVATION OF THE MITOGEN-ACTIVATED PROTEIN KINASE ERK5 REGULATES THE DEVELOPMENT AND GROWTH OF HEPATOCELLULAR CARCINOMA 100
Ganglioside composition correlates with the malignant phenotype of cholangiocarcinoma cells and modulates cell adhesion 100
THE ACTIN CYTOSKELETON AS A NOVEL TARGET OF AMP-ACTIVATED PROTEIN KINASE (AMPK) IN HEPATIC STELLATE CELLS 99
Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells 98
CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cells 97
Aberrant Glycosphingolipid Pattern in Human Cholangiocarcinoma Stem-Like Subsets 97
Severe hypoxia defines heterogeneity and selects highly immature progenitors within clonal erythroleukemia cells. 97
ERK5/BMK1 is indispensable for optimal colony-stimulating factor 1 (CSF-1)-induced proliferation in macrophages in a Src-dependent fashion. 94
Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with Colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2 94
Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO positive leukemia cells 92
Mitogen-activated protein kinases and Hedgehog-GLI signaling in cancer: A crosstalk providing therapeutic opportunities? 92
The c-Jun-N-terminal-Kinase inhibitor SP600125 enhances the butyrate derivative D1-induced apoptosis via caspase 8 activation in Kasumi 1 t(8;21) acute myeloid leukaemia cells. 88
Interleukin-4 rapidly down-modulates the macrophage colony-stimulating factor receptor in murine macrophages. 87
Incubation of murine bone marrow cells in hypoxia ensures the maintenance of marrow-repopulating ability together with the expansion of committed progenitors. 86
The involvement of a Nanog, Klf4 and c-Myc transcriptional circuitry in the intertwining between neoplastic progression and reprogramming 86
Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma 86
ERK5 differentially regulates PDGF-induced proliferation and migration of hepatic stellate cells. 85
Fatty acids regulate the biology of cholangiocarcinoma cells 82
Low M(r) phosphotyrosine protein phosphatase activity on fibroblast growth factor receptor is not associated with enzyme translocation. 81
HYPOXIA SUPPRESSES BCR/ABL AND SELECTS IMATINIB-INSENSITIVE PROGENITORS WITHIN CLONAL CML POPULATIONS. 81
Low Mr Phosphotyrosine Protein Phosphatase Associates and Dephosphorylates p125 Focal Adhesion Kinase, Interfering with Cell Motility and Spreading 80
EPIGENETIC MODIFICATIONS IN A T(8;21) ACUTE MYELOID LEUKAEMIA CELL LINE CAUSED BY ADMINISTRATION OF TWO HDAC INHIBITORS, VPA AND SAHA 80
Tryptophan availability selectively limits NO-synthase induction in macrophages. 79
Possible mechanisms and function of nuclear trafficking of the colony-stimulating factor-1 receptor. 79
Cytoskeletal rearrangement by the mitogen-activated protein kinase ERK5 interferes with the motile and invasive phenotype of hepatocellular carcinoma cells 79
ERK5 IS OVEREXPRESSED IN EXPERIMENTAL LIVER INJURY AND IN HEPATOCELLULAR CARCINOMA (HCC) AND IS MODULATED BY SOLUBLE FACTORS IN HCC CELLS 79
ACTIVATION OF ERK5, A MEMBER OF THE MAPK FAMILY, DIFFERENTIALLY REGULATES PROLIFERATION AND MIGRATION OF HEPATIC STELLATE CELLS 79
Extracellular signal-regulated kinase 5 regulates the malignant phenotype of cholangiocarcinoma cells 79
Interleukin 2 down-modulates the macrophage colony-stimulating factor receptor in murine macrophages. 78
Opposite effects of different doses of MCSF on ERK phosphorylation and cell proliferation in macrophages. 77
Enhanced Antitumoral Activity and Photoacoustic Imaging Properties of AuNP-Enriched Endothelial Colony Forming Cells on Melanoma 75
Transmodulation of cell surface regulatory molecules via ectodomain shedding. 73
Glutamine availability controls bcr/abl protein expression and functional phenotype of chronic myeloid leukemia cells endowed with stem/progenitor cell potential 73
c-Rel AND p27Kip ARE DOWNSTREAM TARGETS OF ERK5 IN HEPATOCELLULAR CARCINOMA (HCC) IN VIVO AND IN VITRO 72
Focal adhesion kinase is redistributed to focal complexes and mediates cell spreading in macrophages in response to M-CSF. 72
The low-molecular-weight phosphotyrosine protein phosphatase, when overexpressed, reduces the mitogenic response to macrophage colony-stimulating factor and tyrosine phosphorylation of its receptor. 70
CYTOSKELETAL REARRANGEMENT BY THE MITOGEN-ACTIVATED PROTEIN KINASE ERK5 INTERFERES WITH THE MOTILE AND INVASIVE PHENOTYPE OF HEPATOCELLULAR CARCINOMA CELLS 69
Constitutive activation of the MAPK pathway mediates v-fes-induced mitogenesis in murine macrophages. 67
Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators 64
Butyrates as single drug induce histone acetylation and granulocytic maturation: possible selectivity on core binding factor-acute myeloid leukemia blasts. 61
Lipid rafts: integrated platforms for vascular organization offering therapeutic opportunities. 61
Inhibition of ERK5 elicits cellular senescence in melanoma via the cyclin-dependent kinase inhibitor p21 61
Hepatocyte-specific deletion of HIF2α prevents NASH-related liver carcinogenesis by decreasing cancer cell proliferation 60
CSF1 Determines CSF1R Cytoplasmic Nuclear Shuttling in Breast Cancer Cells 58
The Culture-Repopulating Ability Assays and Incubation in Low Oxygen: A Simple Way to Test Drugs on Leukaemia Stem or Progenitor Cells 57
Playing the Whack-A-Mole Game: ERK5 Activation Emerges Among the Resistance Mechanisms to RAF-MEK1/2-ERK1/2- Targeted Therapy 57
L’oncogene fes e la fosfotirosino-fosfatasi citosolica a basso peso molecolare interferiscono con la proliferazione e l’adesione cellulare 55
The profile on intracellular gangliosides correlates with the malignant phenotype of cholangiocarcinoma cells and modulates cells adhesion 55
Salarin C inhibits maintenance of hypoxia-selected Chronic Myeloid Leukemia progenitor cells 55
CHARACTERIZATION OF SIGNALS LINKING THE MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR TO THE FOCAL ADHESION KINASE 53
GLUCOSE AVAILABILITY IN HYPOXIA REGULATES THE SELECTION OF CML PROGENITOR SUBSETS WITH DIFFERENT RESISTANCE TO IMATINIB-MESYLATE 51
Anti-β4 integrin autoantibodies in patients with mucous membrane pemphigoid: a retrospective analysis from a tertiary centre in Italy 50
BORTEZOMIB SPECIFICALLY TARGETS A SUBSET OF HYPOXIA-SELECTED CML STEM CELLS 50
MAPKS ARE INVOLVED IN THE SURVIVAL AND DIFFERENTIATION OF A T(8;21) ACUTE MYELOID LEUKEMIA CELL LINE AND ARE MODULATED BY THE HDAC INHIBITOR D1 49
HYPOXIA SELECTS DRUG-INSENSITIVE PROGENITORS WITHIN CLONAL LEUKAEMIA CELL POPULATIONS 49
The Hedgehog-GLI Pathway Regulates MEK5-ERK5 Expression and Activation in Melanoma Cells 49
ENERGY RESTRICTION REGULATES BCR/ABL EXPRESSION IN CHRONIC MYELOID LEUKAEMIA CELLS VIA TRANSCRIPTIONAL/POST-TRANSCRIPTIONAL CONTROL 48
Lactate maintainsBCR/Abl expression and signalinginChronic Myeloid Leukemia cells under nutrient restriction 48
GLEEVEC-RESISTANT CML STEM AND PROGENITOR CELLS ARE SENSITIVE TO HIF-INHIBITING DRUGS 47
TNF-alpha-converting enzyme cleaves the macrophage colony-stimulating factor receptor in macrophages undergoing activation. 46
Targeting chronic myeloid leukemia stem cells with ERK5 pathway inhibitors 46
INCUBATION OF MURINE ERYTHROLEUKEMIA CELLS IN SEVERE HYPOXIA INDUCES MASSIVE APOPTOSIS PARALLELED BY AKT AND ERK5 CLEAVAGE 46
HDAC INHIBITORS IN COMBINATION WITH HYPOMETHYLATING AGENTS INDUCE SPECIFIC CHROMATIN MODIFICATION AND TRANSCRIPTIONAL ACTIVATION IN CBF/AML CELLS 43
SPECIFIC DEGRADATION OF THE AML1-ETO/COREPRESSOR COMPLEX BY A NOVEL ORAL HYDROXAMIC ACID DERIVATIVE 43
Effects of a human myeloid chronic leukemia cell line (K562) on in vivo angiogenesis 41
ROLE OF ERK5 IN THE SURVIVAL OF MYELOID LEUKEMIA CELLS IN HYPOXIA 41
Bortezomib Specifically Targets a Subset of Hypoxia-Selected CML Stem Cells 41
ERK5-INHIBITION AS A NOVEL APPROACH TO TARGET CML STEM CELLS 41
ERK5 inhibition elicits cellular senescence in human melanoma cells 41
TRAIL IS INVOLVED IN HYPOXIA-INDUCED APOPTOSIS OF ACUTE MYELOID LEUKEMIA T(8;21)-POSITIVE CELLS 40
ACETYLATION INDUCED BY BUTYRATES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA CAN LEAD TO DIFFENTIATION 40
EPIGENETIC MODIFICATIONS IN A T(8;21) ACUTE MYELOID LEUKEMIA CELL LINE CAUSED BY ADMINISTRATION OF THE HDAC INHIBITOR D1 38
Expression and Role in the Proliferation of the Colony-Stimulating Factor-1 Receptor in Breast Cancer Cells 36
Totale 9.823
Categoria #
all - tutte 29.326
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.326


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.033 0 180 77 155 251 242 224 286 205 155 210 48
2020/20211.475 133 155 50 157 69 164 77 109 143 205 83 130
2021/2022940 59 66 44 56 50 54 49 54 68 59 140 241
2022/20232.234 189 366 125 159 155 382 299 142 284 16 67 50
2023/2024886 30 84 122 35 58 114 54 200 25 39 86 39
2024/2025295 218 77 0 0 0 0 0 0 0 0 0 0
Totale 10.133